Life science Content Management Solutions - Veeva Systems EU
Commercial Content
Accelerate Approved Content with AI
Deliver highly personalized and compliant content faster and at scale.
Click for sound
50 %
average increase in speed to market
40 %
growth in content reuse with modular content
20 %
reduction in cost to create content
Veeva Acquires Copli, Launches Veeva Falcon MLR to Accelerate Content Review
Fastest Path to Approved Content with AI
[Assistive AI Vault AI in PromoMats
Drive productivity and speed with conversational AI directly in your content workflow. Agents check document quality, build claims library, and create custom agents.
\
Learn More](/content/eu/products/ai-for-promomats/index.html) [Agentic MLR™ Veeva Falcon MLR
Targeting a 70% reduction in manual labor within five years, Veeva Falcon MLR delivers agentic MLR, automating content reviews for marketing, agency, and MLR teams.
\
Learn More](https://copli.io/)
Fastest path to approved content with AI
eBook
Building the Future of MLR with AI
Learn what process improvements support AI’s success and keep MLR review in focus.
Our Customers
Leverage pharma leaders’ insights to create an agile end-to-end content life cycle
Click for sound
[****Otsuka Europe and Bayer AG**: Transforming the Content Supply Chain with Veeva PromoMats and Vault CRM**
Read Customer Story](/content/eu/customer-stories/otsuka-europe-bayer-transforming-the-content-supply-chain-with-veeva-promomats-and-vault-crm/index.html) [**7 Steps to Accelerating MLR: How **Moderna** Launched Vault AI in PromoMats**
Read Customer Story](/content/eu/customer-stories/modernas-7-step-guide-to-vault-ai-in-promomats/index.html) [****Angelini Pharma**’s Agile Journey from Crisis to Global Impact**
Read Blog](/content/eu/blog/scaling-content-excellence-angelini-pharmas-agile-journey-from-crisis-to-global-impact/index.html)
“AI in pharma content review has officially crossed the line from interesting concept to strategic priority.”
Tareek Turner
Associate Director, HPRC and Content Personalization/Automation, Boehringer Ingelheim
“AI is changing the way we work and will touch every piece of the content ecosystem. We’re uncovering ways AI can help automate or augment our processes like content creation, MLR, and deployment to help us deliver content effectively and efficiently.”
Karen Patel
Senior Director, Content Platforms and Delivery, Bristol Myers Squibb
“From a project standpoint, implementation was very easy because Vault AI Quick Check Agent runs alongside our regular workflow without causing any disruption.”
Jason Benagh
Global Marketing Operations Director, Moderna
“The area where GenAI has the most potential is MLR and it’s exciting to see Veeva embrace that with Vault AI in PromoMats.”
Dr. Samin Saeed
Vice President, Early Assets Medical, GSK
“With PromoMats, we gained crucial insights that helped us identify opportunities to reuse, repurpose or withdraw assets, enabling content tailoring at scale.”
Francesco Iaccarino
Commercial Ops & HR Demand Manager, Angelini Pharma S.p.A.
Commercial Content
Delivering compliant content across channels, geographies, and brands.
AI for PromoMats Delivering better content faster with AI.
Claims Management Automate claims substantiation for compliant, consistent content.
Insights and Performance Analytics Power your content strategy with engagement metrics from CRM.
Frequently Asked Questions
Find all the information you're looking for
How can biopharmas accelerate the MLR review process?
Accelerating the MLR process starts with replacing fragmented, manual workflows with a connected platform that supports the end-to-end content lifecycle. By centralizing all assets in a unified content management system, biopharmas can automate processes and enable real-time collaboration across medical, legal, and regulatory teams, reducing the time to approved content by up to 75%.
Modern strategies to streamline MLR include:
- Agentic AI for MLR: Manages multi-step processes autonomously and is uniquely capable of handling compliance pre-checks and flagging risks while avoiding a rework of the end-to-end content supply chain.
- Claims management and harvesting: Digital tools auto-link approved claims to references in a centralized claims library, reducing the effort by 90% compared to manual verification and linking. Claims harvesting creates claims from link annotations on steady-state documents, making library maintenance easier.
- Content reuse: Repurposing pre-approved content across multiple assets and channels ensures brand integrity and accuracy while driving significant cost savings and operational efficiency.
- Tier-based reviews: Business rules move a large percentage of content through streamlined tiers compliantly and efficiently, freeing resources to focus on high-value, high-risk material.
- Content similarity: Comparing derivative content with scoring helps reviewers prioritize where to spend time during review and approval.
How does AI reduce our MLR cycle times?
AI reduces MLR cycle times by taking on more of the low-value tasks medical, legal, and regulatory (MLR) reviewers handle, from editorial and compliance checks to claims substantiation. By rethinking the division of human and agentic labor, biopharma could remove 70% of manual MLR work and increase content speed to market by up to 80%.
Assistive AI in Veeva PromoMats paired with Agentic MLRTM drive the fastest path to approved content:
- Assistive AI: Vault AI in PromoMats embeds agentic capabilities in the application to assist users directly in their daily workspace. To drive speed and productivity across the content lifecycle, both standard agents and brand-specific custom agents execute tasks directly for marketing ops, reviewers, and content owners.
- Agentic MLR: Falcon MLR is an autonomous, agentic compliance layer integrated with PromoMats and Veeva MedComms. It executes rigorous reviews of promotional and medical materials, conducting compliance checks against approved labels and local regulations to minimize manual effort.
Implementing AI in MLR modernizes content ideation, review, localization, and approval for more efficient and consistent MLR processes. Ultimately, it drives faster information access for healthcare professionals (HCPs) and patients.
How can biopharmas manage global compliance and regulatory submissions for promotional materials?
Biopharmas manage global compliance for promotional materials with a unified content system that standardizes processes while meeting regional regulatory requirements (e.g., FDA, EMA, and local authorities). Centralized platforms ensure that all content is reviewed, approved, and tracked with full audit trails, role-based access, and version control.
By connecting Veeva PromoMats with Veeva RIM, organizations can automatically generate submission-ready eCTD compliance packages — such as Form FDA-2253 in the U.S. or self-certification documents for the EMA — directly from approved promotional assets. A single source of truth for content and approvals, eliminates manual data entry, shortens submission timelines for post-marketing and pre-clearance filings, and ensures that only the most current, compliant materials are distributed across global markets.
How can biopharmas manage claims and references?
Effective claims management relies on a centralized, structured claims library that connects every claim to its supporting references. Digital tools can automatically link claims to source documents, track usage across assets, and ensure consistency across channels. Automated claims management reduces manual effort, improves traceability, and ensures that every claim used in content is accurate, approved, and compliant — while making it easy to reuse validated claims at scale.
How can biopharmas manage digital assets and maintain brand consistency?
Managing digital assets at scale requires an industry-specific digital asset management (DAM) system that governs how content is created, stored, reused, and distributed. By organizing assets with metadata, version control, and approval status, content teams can ensure that only compliant, on-brand materials are used.
Combined with modular content, DAM enables teams to reuse pre-approved components across channels — maintaining brand consistency while delivering more personalized experiences faster and more efficiently. Leveraging tools like the Veeva PromoMats Brand Portal further streamlines this process by providing an intuitive interface to browse, share, and reuse pre-approved promotional assets.
Where can I find more information about Veeva PromoMats?
You can read more about Veeva PromoMats, attend Veeva Commercial Summit, or contact your Veeva account team for more information.
What is a biopharma omnichannel strategy framework?
A biopharma omnichannel strategy framework connects customer insights, engagement channels, and cross-functional teams to deliver coordinated engagement with healthcare professionals. Together, the following capabilities help life sciences companies create more consistent and personalized HCP experiences:
- Customer insights and segmentation
- Integrated engagement channels
- Cross-functional coordination across teams
- Personalized scientific content
- Engagement analytics and measurement
How can Veeva help with managing data privacy and consent for digital campaigns?
Veeva’s platform provides built-in tools for managing data privacy and consent. It helps companies capture and track customer consent preferences, ensures all digital content is compliant, and audit-ready to meet regulatory requirements like GDPR. This centralized approach ensures that field and marketing teams only engage with HCPs through their preferred channels, maintaining trust and regulatory integrity across every touchpoint.
How do you measure the impact of digital engagement?
Research shows that coordinated interactions are significantly more likely to result in a prescription than disconnected activities. By measuring these connections, organizations can optimize resource allocation and ensure educational efforts are focused on the HCPs and patient populations where they will have the greatest impact on health outcomes. Digital engagement is typically measured using metrics such as:
- Participation in webinars or virtual meetings
- Engagement with digital content
- Email engagement and follow-up interactions
- Frequency and quality of HCP interactions
- Progression of engagement across channels
How can Veeva help biopharmas increase omnichannel impact?
Veeva helps biopharmas increase omnichannel impact through the Vault CRM Suite, integrating key commercial applications and processes for more effective field planning and engagement across personal and digital channels. Vault CRM is a deep application for life sciences that connects sales, marketing, and medical teams on a single platform with a unified customer database for next-generation engagement.
- Vault CRM Engage provides a digital platform to meet, connect, and share with HCPs through compliant virtual meetings and chat.
- Vault CRM Approved Email allows reps to send compliant emails to HCPs in a unified experience.
- Vault CRM Events Management streamlines the execution of compliant live, virtual, and hybrid events.
- Vault CRM Campaign Manager coordinates sales and marketing engagement in unified campaigns, aligning both non-personal and field channels.
These applications automatically capture engagement data in Vault CRM to provide a 360-degree view of the customer, enabling more intelligent planning and more impactful future conversations.
Where can I find more information about the Vault CRM Suite?
You can read more about Vault CRM Suite, attend Veeva Commercial Summit, or contact your Veeva account team for more information.